Diabetes

Papers
(The H4-Index of Diabetes is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
352-OR: Regulation of Melanocortin Receptor 4 (MC4R) Ciliary Trafficking175
983-P: Long-Term Improvement in CGM-Measured Glycemic Control in Adults with Type 2 Diabetes Not Treated with Insulin—Real-World Data96
1082-P: Online Clinician Education Results in Performance Changes in Clinical Practice Related to Obesity Management in Patients With and Without Type 2 Diabetes91
1465-P: Identification of GCK Gene Variants and Clinical Characterization in Japanese Pediatric MODY2 Cases81
661-P: Use of a Sequential Continuous Glucose Monitoring with or without Exercise Tracker on Glycaemic Control in Middle-Aged Patients with Diabetes Mellitus78
2054-LB: Mitigating Adipose Tissue Dysfunction and Insulin Resistance in Obesity via SVEP1 Peptide-Mediated Suppression of Adipose Tissue Macrophage-Induced Inflammation74
1081-P: Trends in Treatment Goal Attainment of Cardiovascular Risk Factors in Chilean Adults with Diabetes Mellitus—Results from the National Health Survey 2016–201773
141-LB: Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) from a U.S. Payer Perspective in Patients with Type 2 Di72
1682-P: Factors Associated with Postprandial Suppression of Endogenous Glucose Production in People without Diabetes67
1708-P: Development of a Needle-Free, Self-Applied Microarray Patch for GLP-1 Delivery66
880-P: Effects of Energy Dosing on Safety and Efficacy in an Open-Label Study of Endoscopic Pulsed Electric Field Induced Electroporation in Type 2 Diabetes (REGENT-1 Trial)66
71-OR: ADA Presidents' Select Abstract: HLA-Focused Meta-Genetic Risk Score (GRS) Performance in Populations of Diverse Ancestry with Type 1 Diabetes66
574-P: Meta-analysis Shows Mind- and Body-Based Interventions Improve Glycemic Control in Patients with Type 2 Diabetes62
249-OR: Cystatin C Predicts Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients with and among Those without Type 2 Diabetes59
1478-P: Polygenic Risk Score Predicts Incident Cardiovascular Disease in People with Diabetes at Borderline or Intermediate 10-Year ASCVD Risk58
2037-LB: Considerations for Calculating and Reporting CGM Wear-Time in Research Settings56
1638-P: Oxidized Lipids Cause Ceramide Accumulation and Insulin Resistance in Skeletal Muscle48
468-P: Association between Sudomotor Function and Coronary Atherosclerosis in Patients with Type 2 Diabetes48
261-OR: Validation of Mitraa, a GPT-Based Conversational Model for Enhancing Diabetes Self-Management and Education47
1034-P: No “Honeymoon” for Youth, in Particular Blacks, Diagnosed with Diabetes during the First Year of the COVID-Pandemic46
1740-P: Regulation of Endocrine Cell Alternative Splicing Revealed by Single-Cell RNA Sequencing in Type 2 Diabetes45
1078-P: Elderly Patient with DM2 during the COVID-Pandemia: Forgotten but Good Glycemic Control44
921-P: Impact of Heart Rate and Step Count on Deep Learning Glucose Prediction Models during Physical Activity44
1451-P: Peri-Islet Fibrosis in Cystic Fibrosis Is Associated with Altered Alpha-Cell Phenotype40
697-P: Evaluation of Acceptance and Commitment Therapy on Glycemic Control in Type 2 Diabetes Patients40
68-OR: Influence of the Type 1 Diabetes Genetic Risk Score on Response to Immunotherapies for Type 1 Diabetes Prevention39
1558-P: Immunological Role of Hybrid Insulin Peptide in Type 1 Diabetes in Asia38
727-P: A New HbA1c Test Based on a Cellular Stiffness Measurement of Red Blood Cells38
171-LB: Estimating the Immunological Risk for Type 1 Diabetes from a CGM-Based One Week Self-Administered Home Test38
1591-P: Effects of Light Exposure during Sleep on Glycemic Control in Type 1 Diabetes38
240-OR: Quantifying Glucose Utilization and Endogenous Glucose Production during Resistance Exercise in People with Type 1 Diabetes (T1D)37
1586-P: Association between PCSK7 Levels and NAFLD Severity in KADEM Study37
252-OR: Maternal Obesity and Diabetes during Pregnancy and Quantitative Checklist for Autism in Toddlers (QCHAT) Scores in Offspring34
633-P: Insight to the Association between Serum Fibroblast Growth Factor 23 Levels and Presarcopenia in Nondiabetic Individuals—A Longitudinal Cohort Study34
280-OR: Insulin Sensitivity following an In-Home Sleep and Circadian Intervention for Habitually Short-Sleeping Adolescents34
478-P: Application of Plasma Proteomics to Explore Potential Biomarkers of Diabetic Macular Edema34
562-P: A Social Media Intervention Shows Promise to Improve Health Outcomes in Low-Income Immigrants with Type 2 Diabetes—Evidence from a Pilot RCT34
0.12002992630005